Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels
AssigneeMedtronic, Inc.
InventorsBruce Gunderson, Amisha Patel, Chad Bounds, Mark Brown
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedtronic, Inc.
InventorsBruce Gunderson, Amisha Patel, Chad Bounds, Mark Brown
Estimating the term…
A method for identifying and classifying various types of oversensing in implantable medical devices (IMDs), such as implantable cardioverter defibrillators (ICDs), to assist a physician in choosing corrective action to reduce the likelihood of oversensing and inappropriate therapy delivery. Far-field electrogram (EGM) signals are analyzed to detect the occurrence of R-waves, and the result is compared to the number and pattern of R-waves sensed by the IMD and indicated on the marker channel. A marker channel with more sensed R-waves than indicated by analysis of the far-field EGM indicates the presence of oversensing, including double-counting of R-waves, T-wave oversensing, lead malfunction or failure, poor lead connections, noise associated with electromagnetic interference, non-cardiac myopotentials, etc. Identification of the type of oversensing may be determined by analysis of the number and pattern of marker channel sensed R-waves with respect to the timing of the R-waves detected from the far-field EGM.
A method of detecting the occurrence of intrinsic depolarizations of a heart chamber comprising:
A method of detecting the occurrence of intrinsic depolarizations of a heart chamber comprising:
A method of identifying oversensing of cardiac R-waves by an implantable medical device (IMD), comprising:
Dependencies are inferred from the claim text.